Who invested in Phorm?
Phorm's investors include Morgan Stanley Investment Management, Canaccord Adams, Mirabaud Securities LLP, Evolution Securities Limited and Morgan Stanley & Co. International plc.
United Kingdom · Funded startup
3 rounds we have observed, with the 5 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$98Mraised across 3 rounds since 2008, from 3 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
No investor was named in the report.
From a historical funding record
Reported by phorm.com
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Phorm's investors include Morgan Stanley Investment Management, Canaccord Adams, Mirabaud Securities LLP, Evolution Securities Limited and Morgan Stanley & Co. International plc.
Phorm has raised $98M across 3 rounds since 2008.
Phorm's most recent round was an Undisclosed round of $8.9M in Apr 2015.
Phorm's largest round on record is $65M (Series A), in Mar 2008.
Phorm's first round on record, in Mar 2008, was backed by Morgan Stanley Investment Management, Canaccord Adams and Morgan Stanley & Co. International plc.
Phorm's latest named round is an Undisclosed round, in Apr 2015.
Phorm is based in the United Kingdom.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.